S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
NASDAQ:NEO

NeoGenomics News Headlines

$8.39
-0.50 (-5.62%)
(As of 05/18/2022 04:00 PM ET)
Add
Compare
Today's Range
$8.31
$8.94
50-Day Range
$7.38
$17.90
52-Week Range
$7.26
$54.74
Volume
1.58 million shs
Average Volume
1.94 million shs
Market Capitalization
$1.05 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.86
Get NeoGenomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

NeoGenomics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NEO
News Sentiment

-0.15

0.25

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NEO Articles
This Week

3

4

NEO Articles
Average Week



NeoGenomics (NASDAQ:NEO) News Headlines Today

SourceHeadline
streetinsider.com logoNeoGenomics (NEO) Appoints Lynn Tetrault as Interim CEO - StreetInsider.com
streetinsider.com - May 16 at 10:03 PM
finance.yahoo.com logoNeoGenomics Appoints Lynn Tetrault Interim CEO
finance.yahoo.com - May 16 at 7:53 AM
MarketBeat logoStockNews.com Upgrades NeoGenomics (NASDAQ:NEO) to "Sell"
americanbankingnews.com - May 14 at 3:50 AM
finance.yahoo.com logoNeoGenomics Liquid Biopsy Subsidiary Inivata and Collaborators Present New Data Further Validating the Application of its RaDaR(R) MRD and InVisionFirst(R)-Lung Tests at the 2022 ASCO Annual Meeting
finance.yahoo.com - May 10 at 10:11 AM
finance.yahoo.com logoNeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary - Yahoo Finance
finance.yahoo.com - May 9 at 2:21 PM
finance.yahoo.com logoNeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
finance.yahoo.com - May 9 at 8:39 AM
MarketBeat logoNeoGenomics (NASDAQ:NEO) Reaches New 52-Week Low at $9.13
americanbankingnews.com - May 8 at 3:02 AM
benzinga.com logoNeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference - Benzinga - Benzinga
benzinga.com - May 5 at 11:23 PM
finance.yahoo.com logoNeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference
finance.yahoo.com - May 5 at 6:23 PM
finance.yahoo.com logoInvestors in NeoGenomics (NASDAQ:NEO) have unfortunately lost 76% over the last year
finance.yahoo.com - May 5 at 8:22 AM
MarketBeat logoNeoGenomics (NASDAQ:NEO) Rating Increased to Sell at StockNews.com
americanbankingnews.com - April 30 at 1:16 AM
nasdaq.com logoNeoGenomics Now the Least Expensive vs. Binance Coin This Year - Nasdaq
nasdaq.com - April 28 at 3:42 PM
benzinga.com logoRaymond James Maintains Outperform on NeoGenomics, Lowers Price Target to $15 - Benzinga - Benzinga
benzinga.com - April 28 at 10:42 AM
seekingalpha.com logoNeoGenomics, Inc. 2022 Q1 - Results - Earnings Call Presentation
seekingalpha.com - April 27 at 2:12 PM
finance.yahoo.com logoNeoGenomics Reports Revenue of $117 Million in the First Quarter
finance.yahoo.com - April 27 at 7:53 AM
MarketBeat logoNeoGenomics (NASDAQ:NEO) Reaches New 1-Year Low at $10.64
americanbankingnews.com - April 27 at 3:26 AM
globenewswire.com logoBragar Eagel & Squire, PC Is Investigating NeoGenomics - GlobeNewswire
globenewswire.com - April 21 at 8:10 AM
finance.yahoo.com logoEarnings Preview: NeoGenomics (NEO) Q1 Earnings Expected to Decline
finance.yahoo.com - April 20 at 5:09 PM
finance.yahoo.com logoGlobal Lung Cancer Diagnostics Market to Reach $3.4 Billion by 2026 - Yahoo Finance
finance.yahoo.com - April 18 at 10:24 AM
benzinga.com logoRaymond James Maintains Outperform on NeoGenomics, Lowers Price Target to $18 - Benzinga
benzinga.com - April 18 at 5:23 AM
benzinga.com logoMorgan Stanley Maintains Equal-Weight on NeoGenomics, Lowers Price Target to $27 - Benzinga - Benzinga
benzinga.com - April 12 at 2:21 PM
finance.yahoo.com logoNeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022 - Yahoo Finance
finance.yahoo.com - April 11 at 6:12 PM
finance.yahoo.com logoNeoGenomics Announces That Inivata Liquid Biopsy Subsidiary and Collaborators Have Published Clinical Validation Data for RaDaR(TM) Assay MRD Assay at AACR 2022
finance.yahoo.com - April 11 at 6:12 PM
finance.yahoo.com logoNeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions Supporting Biopharma R&D
finance.yahoo.com - April 11 at 9:39 AM
finance.yahoo.com logoNeoGenomics Schedules its First Quarter 2022 Earnings Release for April 27, 2022
finance.yahoo.com - April 8 at 9:02 PM
seekingalpha.com logoNeogenomics: Poor Performance, CEO Departure Create Downward Share Price Spiral - Seeking Alpha
seekingalpha.com - April 8 at 4:02 PM
globenewswire.com logoNEO EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages NeoGenomics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – NEO - GlobeNewswire
globenewswire.com - April 6 at 5:52 PM
benzinga.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - - Benzinga
benzinga.com - April 6 at 7:51 AM
benzinga.com logoONGOING INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses o - Benzinga
benzinga.com - April 5 at 4:46 PM
benzinga.com logoBragar Eagel & Squire, P.C. Is Investigating Natera, Li-Cycle, Barclays, and NeoGenomics and Encourages I - Benzinga
benzinga.com - April 4 at 11:33 PM
globenewswire.com logoBragar Eagel & Squire, PC Is Investigating Natera, Li-Cycle, Barclays, and NeoGenomics and Encourages Investors to Contact the Firm - GlobeNewswire
globenewswire.com - April 4 at 11:33 PM
globenewswire.com logoCancer Diagnostics Market is Expected to Surpass USD 185 Billion by 2026, Assesses DelveInsight - GlobeNewswire
globenewswire.com - April 4 at 6:33 PM
benzinga.com logoSHAREHOLDER ALERT - Labaton Sucharow Investigating NeoGenomics Inc. - NEO - Benzinga - Benzinga
benzinga.com - April 4 at 6:33 PM
benzinga.com logoNEO INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors with Losses t - Benzinga
benzinga.com - April 4 at 6:33 PM
businesswire.com logoNEOGENOMICS ALERT: Bragar Eagel & Squire, P.C. is Investigating NeoGenomics, Inc. on Behalf of NeoGenomics Stockholders and Encourages Investors to Contact the Firm - Business Wire
businesswire.com - April 2 at 4:32 AM
businesswire.com logoBiognosys Presenting Data on its TrueDiscovery™ and TrueTarget™ Proteomics Platforms at the AACR Annual Meeting 2022 - Business Wire
businesswire.com - April 1 at 3:48 AM
businesswire.com logoLost Money in NeoGenomics, Inc.? - Business Wire
businesswire.com - April 1 at 3:48 AM
benzinga.com logoONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of - Benzinga
benzinga.com - March 31 at 5:14 PM
benzinga.com logoInvestigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of NeoGenomics, Inc. (NASDAQ: NEO) Investors
benzinga.com - March 30 at 6:48 PM
benzinga.com logoINVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,0 - Benzinga
benzinga.com - March 30 at 4:11 PM
benzinga.com logoNeoGenomics Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at NeoGenomics, Inc. - Ben - Benzinga
benzinga.com - March 30 at 10:00 AM
benzinga.com logoMid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide - Benzinga - Benzinga
benzinga.com - March 29 at 11:57 PM
benzinga.com logoMid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide - Benzinga - Benzinga
benzinga.com - March 29 at 11:57 PM
benzinga.com logoB of A Securities Downgrades NeoGenomics to Neutral, Lowers Price Target to $18 - Benzinga - Benzinga
benzinga.com - March 29 at 6:54 PM
marketwatch.com logoNeoGenomics Shares Drop 36% After CEO Departure, Guidance, Analysts' Cuts - MarketWatch
marketwatch.com - March 29 at 6:54 PM
finance.yahoo.com logoNeoGenomics Stock Tanks After CEO Exits Amid Sales, Profitability Maelstrom
finance.yahoo.com - March 29 at 6:54 PM
benzinga.com logoNeoGenomics, Inc. Investors: Company Investigated by the Portnoy Law Firm
benzinga.com - March 29 at 12:52 PM
investorplace.com logoWhy Is NeoGenomics (NEO) Stock Down Today?
investorplace.com - March 29 at 12:02 PM
streetinsider.com logoUPDATE: Stephens Downgrades Neogenomics (NEO) to Equal Weight - StreetInsider.com
streetinsider.com - March 29 at 8:38 AM
benzinga.com logoThe Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, - Benzinga
benzinga.com - March 29 at 8:38 AM
Get NeoGenomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.